Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design [0.03%]
米托麦克压入式腹腔喷雾化疗联合系统化疗治疗阑尾和结直肠腹膜转移的多中心剂量递增一期试验：原理与设计
Mustafa Raoof,Kevin M Sullivan,Paul H Frankel et al.
Mustafa Raoof et al.
Objectives: Peritoneal metastasis (PM) from appendiceal cancer or colorectal cancer (CRC) has significant morbidity and limited survival. Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a minimally invasiv...
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne [0.03%]
腹腔内微粒化学治疗（PIPAC）在多模式治疗寡转移性胃癌患者中的作用：PIPAC VEROne III期多中心随机试验
Francesco Casella,Maria Bencivenga,Riccardo Rosati et al.
Francesco Casella et al.
Objectives: Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis. Cytoreductive surgery...
Lakhdar Khellaf,Stéphanie Nougaret,Sébastien Carrère et al.
Lakhdar Khellaf et al.
Importance of biopsy site selection for peritoneal regression grading score (PRGS) in peritoneal metastasis treated with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) [0.03%]
选择活检部位对腹膜转移复发分级评分（PRGS）在反复使用加压式腹腔喷雾化疗（PIPAC）治疗中的重要性
Mojib Fallah,Sönke Detlefsen,Alan P Ainsworth et al.
Mojib Fallah et al.
Objectives: The four-tiered peritoneal regression grading score (PRGS) is used for histological response evaluation in patients with peritoneal metastasis (PM) treated with pressurized intraperitoneal aerosol chemotherapy...
Perioperative anaesthetic management in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a retrospective analysis in a single tertiary care cancer centre [0.03%]
肿瘤细胞减灭术(CRS)联合腹腔热灌注化疗(HIPEC)的麻醉管理：单一三级医疗机构的回顾性分析
Raghav Gupta,Nishkarsh Gupta,Prashant Sirohiya et al.
Raghav Gupta et al.
Objectives: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with increased morbidity and mortality. We retrospectively analysed the perioperative anesthetic management in p...
Role of prophylactic HIPEC in non-metastatic, serosa-invasive gastric cancer: a literature review [0.03%]
预防性HIPEC在无转移的胃癌浆膜浸润型胃癌中的作用：文献综述
Aditya R Kunte,Aamir M Parray,Manish S Bhandare et al.
Aditya R Kunte et al.
The role of prophylactic hyperthermic intraperitoneal chemotherapy (p-HIPEC) in serosa invasive gastric cancers without gross or microscopic peritoneal disease, to reduce the rate of peritoneal relapse is an area of ongoing research. Althou...
The effect of metastasis location on outcome after cytoreductive surgery and heated intraperitoneal chemotherapy [0.03%]
减瘤手术和加热腹腔内化疗后转移部位对预后的影响
Lise Hommelgaard,Jonas A Funder,Victor J Verwaal
Lise Hommelgaard
Objectives: This study aims to evaluate how metastases in the seven topographical regions of the simplified peritoneal cancer index (sPCI) affect the survival of patients treated with cytoreductive surgery (CRS) and heate...
Abdominal tissue concentrations and penetration of carboplatin in a HIPEC procedure ‒ assessment in a novel porcine model [0.03%]
腹腔热灌注化疗(carboplatin HIPEC)过程中组织浓度和铂渗透评价——新型猪模型的应用
Elisabeth K Petersen,Mats Bue,Christina Harlev et al.
Elisabeth K Petersen et al.
Objectives: Peritoneal dissemination from intraabdominal cancers is associated with poor prognosis and rapid disease progression. Hyperthermic intraperitoneal chemotherapy (HIPEC) is an antineoplastic treatment, which has...
Can baseline quality of life scores predict for morbidity and survival after CRS and HIPEC: a prospective study of 151 patients [0.03%]
术前生活质量评分能否预测结直肠癌腹腔细胞减灭术及 hyperthermic腹腔内化疗后的生存及预后：一项前瞻性研究（151 例患者）
Claramae Shulyn Chia,Chin-Ann Johnny Ong,Hong-Yuan Zhu et al.
Claramae Shulyn Chia et al.
Objectives: Various studies have shown that good quality of life (QoL) can be achieved after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). There is prognostic value of baseline QoL in ...
A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) [0.03%]
关于经压力化腹腔喷雾化疗(PIPAC)治疗的腹膜转移癌患者的生存质量(QoL)系统性综述
Zhenyue Li,Louis Choon Kit Wong,Rehena Sultana et al.
Zhenyue Li et al.
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has recently emerged as a palliative alternative for patients with unresectable peritoneal metastasis (PM). Quality of life (QoL) has increasingly been ...